ProShare Advisors’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$150K Sell
34,949
-9,135
-21% -$50.9K ﹤0.01% 1648
2025
Q4
$395K Buy
44,084
+1,409
+3% +$8.73K ﹤0.01% 1272
2025
Q3
$158K Sell
42,675
-8,501
-17% -$23.2K ﹤0.01% 1754
2025
Q2
$99.8K Buy
51,176
+11,928
+30% +$24.8K ﹤0.01% 1878
2025
Q1
$69.1K Sell
39,248
-11,812
-23% -$26.9K ﹤0.01% 1906
2024
Q4
$136K Buy
51,060
+16,801
+49% +$43.3K ﹤0.01% 2000
2024
Q3
$78.5K Buy
34,259
+14,746
+76% +$45K ﹤0.01% 1919
2024
Q2
$57K Sell
19,513
-6,660
-25% -$20.3K ﹤0.01% 1733
2024
Q1
$95.3K Buy
26,173
+2,062
+9% +$3.96K ﹤0.01% 1831
2023
Q4
$36.4K Buy
24,111
+5,186
+27% +$6.67K ﹤0.01% 1888
2023
Q3
$25.4K Sell
18,925
-21
-0.1% -$35 ﹤0.01% 1770
2023
Q2
$34.1K Buy
18,946
+5,246
+38% +$8.92K ﹤0.01% 1808
2023
Q1
$22.7K Sell
13,700
-1,277
-9% -$2.59K ﹤0.01% 1725
2022
Q4
$28.8K Buy
14,977
+2,147
+17% +$4.34K ﹤0.01% 1787
2022
Q3
$30K Sell
12,830
-245
-2% -$700 ﹤0.01% 1700
2022
Q2
$43K Sell
13,075
-16,732
-56% -$73K ﹤0.01% 1722
2022
Q1
$157K Sell
29,807
-4,924
-14% -$27.7K ﹤0.01% 1945
2021
Q4
$295K Buy
+34,731
New +$319K ﹤0.01% 1801

Other funds holding NUVB